綠茶萃取 Green Tea Extract × 心血管疾病
Multiple RCT meta-analyses (PMID 36704803, n=4874 across 55 RCTs; PMID 24675010, n=1536) consistently show that green tea supplementation produces small but statistically robust improvements in surrogate markers - total cholesterol falls roughly 7.
Multiple RCT meta-analyses (PMID 36704803, n=4874 across 55 RCTs; PMID 24675010, n=1536) consistently show that green tea supplementation produces small but statistically robust improvements in surrogate markers - total cholesterol falls roughly 7.6 mg/dL, LDL-C roughly 5.8 mg/dL, and diastolic blood pressure roughly 1 mmHg - which justifies a real signal but only on biomarkers. Crucially, there are NO RCTs of green tea EXTRACT against hard cardiovascular outcomes (MI, stroke, CV mortality); the only hard-outcome benefit (CVD mortality RR ~0.86) comes from observational cohorts of green tea DRINKERS and is subject to residual confounding. Examine's own table confirms every B-grade outcome is a surrogate with no primary clinical CVD endpoint, and a small null RCT (PMID 22144918) tempers extrapolation from the surrogate meta-analyses. Every consulted clinic source (Mayo, Cleveland Clinic, Harvard) explicitly states the benefit is in the beverage, not concentrated extract capsules, and warns about hepatotoxicity; the AHA and ACC make no guideline recommendation. Given a genuine but small surrogate effect, absent extract hard-outcome data, the drinking-vs-extract gap, and a documented hepatotoxicity overhang, the honest extract-supplement grade is C rather than Examine's surrogate-driven B.
評分透明度
所有分數由 7 層證據引擎計算，過程公開可查▸查看完整決策路徑（audit trail）
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.448
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 高品質 SR/MA 顯示 positive (1 篇 > 0 negative)
- tier_strict_requirement_check — Tier 條件達標，未降階
- detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status
社群熱議度高但多繞著減脂代謝與降膽固醇，少有真正『為心血管病吃』的第一手心得；副作用反映集中在心悸與傷肝疑慮，業配評比文密集。
無共識（社群討論多集中於減脂/代謝與降膽固醇，極少有直接針對心血管疾病的第一手實測心得，心血管效益多來自部落格/媒體/廠商論述而非鄉民親身經驗）
- 心悸／心跳加快（咖啡因）
- 失眠、精神緊張
- 腸胃不適／刮胃
- 頭痛、噁心
- 肝指數異常（高劑量膠囊、空腹之肝毒性個案疑慮）
依論壇被提及頻率，非銷售或品質排序。
- 立品（無農藥兒茶素綠茶）
- 野菜村（兒茶素辣椒素 EX）
- 發現茶 兒茶素綠茶
- 新紅薑黃先生（兒茶素版）
- MIHONG 魔度飲
- KGCHECK 聯華食品
⚠️ 列出僅代表「TW 社群討論度高」，不代表本站推薦或背書。本站不販售任何產品、無導購連結。
- 生活型態優化（健康飲食、身體活動、戒菸）
- 史他汀類藥物（適應症族群）
- 戒菸（行為介入合併藥物）
查看 ClaimReview 結構化資料 (JSON-LD)
{
"@context": "https://schema.org",
"@type": "ClaimReview",
"url": "https://gpt-dict.com/claim/CLM-COND-cardiovascular-disease-INT-green-tea-extract-001/",
"datePublished": "2026-06-01",
"author": {
"@type": "Organization",
"name": "gpt-dict.com",
"url": "https://gpt-dict.com"
},
"claimReviewed": "綠茶萃取能改善心血管疾病",
"inLanguage": "zh-TW",
"itemReviewed": {
"@type": "Claim",
"appearance": []
},
"reviewRating": {
"@type": "Rating",
"ratingValue": 2,
"bestRating": 5,
"worstRating": 1,
"alternateName": "🟠 C 薄弱證據"
}
}